176 related articles for article (PubMed ID: 24928218)
1. Rationale and design of a randomized controlled trial of varenicline directly observed therapy delivered in methadone clinics.
Nahvi S; Segal KS; Litwin AH; Arnsten JH
Addict Sci Clin Pract; 2014 Jun; 9(1):9. PubMed ID: 24928218
[TBL] [Abstract][Full Text] [Related]
2. Effect of varenicline directly observed therapy versus varenicline self-administered therapy on varenicline adherence and smoking cessation in methadone-maintained smokers: a randomized controlled trial.
Nahvi S; Adams TR; Ning Y; Zhang C; Arnsten JH
Addiction; 2021 Apr; 116(4):902-913. PubMed ID: 32857445
[TBL] [Abstract][Full Text] [Related]
3. Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial.
Stein MD; Caviness CM; Kurth ME; Audet D; Olson J; Anderson BJ
Drug Alcohol Depend; 2013 Dec; 133(2):486-93. PubMed ID: 23953658
[TBL] [Abstract][Full Text] [Related]
4. Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial.
Nahvi S; Ning Y; Segal KS; Richter KP; Arnsten JH
Addiction; 2014 Sep; 109(9):1554-63. PubMed ID: 24862167
[TBL] [Abstract][Full Text] [Related]
5. The safety and efficacy of varenicline in cocaine using smokers maintained on methadone: a pilot study.
Poling J; Rounsaville B; Gonsai K; Severino K; Sofuoglu M
Am J Addict; 2010; 19(5):401-8. PubMed ID: 20716302
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of a randomized controlled trial of directly observed hepatitis C treatment delivered in methadone clinics.
Litwin AH; Berg KM; Li X; Hidalgo J; Arnsten JH
BMC Infect Dis; 2011 Nov; 11():315. PubMed ID: 22078241
[TBL] [Abstract][Full Text] [Related]
7. Design considerations for a pilot trial using a novel approach for evaluating smoking-cessation medication in methadone-maintained smokers.
Winhusen T; Theobald J; Lewis D
Contemp Clin Trials; 2016 Mar; 47():334-9. PubMed ID: 26944021
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
Koegelenberg CF; Noor F; Bateman ED; van Zyl-Smit RN; Bruning A; O'Brien JA; Smith C; Abdool-Gaffar MS; Emanuel S; Esterhuizen TM; Irusen EM
JAMA; 2014 Jul; 312(2):155-61. PubMed ID: 25005652
[TBL] [Abstract][Full Text] [Related]
9. Rationale, design, and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinics.
Berg KM; Mouriz J; Li X; Duggan E; Goldberg U; Arnsten JH
Contemp Clin Trials; 2009 Sep; 30(5):481-9. PubMed ID: 19505589
[TBL] [Abstract][Full Text] [Related]
10. A pilot clinical trial of varenicline for smoking cessation in black smokers.
Nollen NL; Cox LS; Nazir N; Ellerbeck EF; Owen A; Pankey S; Thompson N; Ahluwalia JS
Nicotine Tob Res; 2011 Sep; 13(9):868-73. PubMed ID: 21498427
[TBL] [Abstract][Full Text] [Related]
11. Interventions to increase adherence to medications for tobacco dependence.
Hollands GJ; Naughton F; Farley A; Lindson N; Aveyard P
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD009164. PubMed ID: 31425618
[TBL] [Abstract][Full Text] [Related]
12. Flexible and extended dosing of nicotine replacement therapy or varenicline in comparison to fixed dose nicotine replacement therapy for smoking cessation: rationale, methods and participant characteristics of the FLEX trial.
Tulloch H; Pipe A; Els C; Aitken D; Clyde M; Corran B; Reid RD
Contemp Clin Trials; 2014 Jul; 38(2):304-13. PubMed ID: 24861558
[TBL] [Abstract][Full Text] [Related]
13. Low incidence of adverse events following varenicline initiation among opioid dependent smokers with comorbid psychiatric illness.
Nahvi S; Wu B; Richter KP; Bernstein SL; Arnsten JH
Drug Alcohol Depend; 2013 Sep; 132(1-2):47-52. PubMed ID: 23332438
[TBL] [Abstract][Full Text] [Related]
14. Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.
Ebbert JO; Hatsukami DK; Croghan IT; Schroeder DR; Allen SS; Hays JT; Hurt RD
JAMA; 2014 Jan; 311(2):155-63. PubMed ID: 24399554
[TBL] [Abstract][Full Text] [Related]
15. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
[TBL] [Abstract][Full Text] [Related]
16. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.
Evins AE; Cather C; Pratt SA; Pachas GN; Hoeppner SS; Goff DC; Achtyes ED; Ayer D; Schoenfeld DA
JAMA; 2014 Jan; 311(2):145-54. PubMed ID: 24399553
[TBL] [Abstract][Full Text] [Related]
17. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
[TBL] [Abstract][Full Text] [Related]
18. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
[TBL] [Abstract][Full Text] [Related]
19. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR;
JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546
[TBL] [Abstract][Full Text] [Related]
20. Adherence to varenicline among African American smokers: an exploratory analysis comparing plasma concentration, pill count, and self-report.
Buchanan TS; Berg CJ; Cox LS; Nazir N; Benowitz NL; Yu L; Yturralde O; Jacob P; Choi WS; Ahluwalia JS; Nollen NL
Nicotine Tob Res; 2012 Sep; 14(9):1083-91. PubMed ID: 22367976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
